Lymphocytes & Sarcoidosis Inflammation Request More Information Trial Objective Researchers want to learn how lymphocytes control inflammation in sarcoidosis patients, and if lymphocytes are the reason why each patient experiences a different outcome of the disease. The goal is to better understand lymphocytes to be able to identify different states of the disease and to identify new treatment options. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Nonsmoking adults who have sarcoidosis, diagnosed through biopsy in the last 18 months, and who are not on immunosuppressive therapy. Age: 18+ Gender: Any Gender Estimated Time Commitment 2 visits, 1 blood draw and one bronchoscopy (optional) × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Christine Riley 303.270.2049 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Institutes of Health Principal Investigators Lisa Maier, MD, MSPH, FCCP + × Lisa Maier, MD, MSPH, FCCP Professor Director, Division of Env & Occ Health Science Core Clinical Lab Chief, Division of Environmental & Occupational Health Sciences Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study, see if you qualify and receive periodic updates about clinical research via email. First Name:* Last Name:* Email Address:* Phone:*
Trial Objective Researchers want to learn how lymphocytes control inflammation in sarcoidosis patients, and if lymphocytes are the reason why each patient experiences a different outcome of the disease. The goal is to better understand lymphocytes to be able to identify different states of the disease and to identify new treatment options.